{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:05:24Z","timestamp":1793232324781,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ebiom.2025.105875","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T13:47:04Z","timestamp":1754401624000},"page":"105875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-6285","authenticated-orcid":false,"given":"Giovanna","family":"Carpi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marva","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"De la Rossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Uplekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestani","family":"Tukvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheed V.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Rodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-2100","authenticated-orcid":false,"given":"Rebecca E.","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105875_bib1","series-title":"Global tuberculosis report 2023","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105875_bib2","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"10.1016\/j.ebiom.2025.105875_bib3","series-title":"Global tuberculosis report 2022","year":"2022"},{"key":"10.1016\/j.ebiom.2025.105875_bib4","series-title":"Module 3: Diagnosis Rapid Diagnostic for tuberculosis detection","article-title":"WHO consolidated guidelines on tuberculosis","year":"2021"},{"key":"10.1016\/j.ebiom.2025.105875_bib5","series-title":"Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for laboratory staff and Clinicians","year":"2022"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105875_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/JCM.02505-15","article-title":"MTBDRplus and MTBDRsl assays: absence of wild-type probe hybridization and implications for detection of drug-resistant tuberculosis","volume":"54","author":"Seifert","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105875_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01075-2016","article-title":"Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"49","author":"Nathavitharana","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105875_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmi.2016.10.022","article-title":"Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives","volume":"23","author":"Sch\u00f6n","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105875_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02169-16","article-title":"Some synonymous and nonsynonymous gyrA mutations in Mycobacterium tuberculosis lead to systematic false-positive fluoroquinolone resistance results with the hain GenoType MTBDRsl assays","volume":"61","author":"Ajileye","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105875_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlab101","article-title":"False detection of rifampicin resistance using Xpert((R)) MTB\/RIF ultra assay due to an A451V mutation in Mycobacterium tuberculosis","volume":"3","author":"Fitzgibbon","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ebiom.2025.105875_bib11","series-title":"Rapid communication: key changes to the treatment of drug-resistant tuberculosis (WHO\/UCN\/TB\/2022.2)","year":"2022"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2025.105875_bib12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ijmyco.2016.09.021","article-title":"Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: a promise for the near future","volume":"5","author":"Dolinger","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ebiom.2025.105875_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.974428","article-title":"Clinical utility of target amplicon sequencing test for rapid diagnosis of drug-resistant Mycobacterium tuberculosis from respiratory specimens","volume":"13","author":"Leung","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2025.105875_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102051","article-title":"Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosis","volume":"127","author":"Kambli","year":"2021","journal-title":"Tuberculosis (Edinb)"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105875_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002794","article-title":"Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: a performance, ease-of-use, and cost evaluation","volume":"16","author":"Colman","year":"2019","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105875_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00974-18","article-title":"Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests","volume":"62","author":"Kandler","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105875_bib17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S1473-3099(24)00263-9","article-title":"Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"24","author":"Schwab","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105875_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1473-3099(24)00586-3","article-title":"Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows","volume":"25","author":"Colman","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105875_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00583-20","article-title":"Assessing nanopore sequencing for clinical diagnostics: a comparison of next-generation sequencing (NGS) methods for mycobacterium tuberculosis","volume":"59","author":"Smith","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105875_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/clinchem\/hvaa092","article-title":"Targeted-sequencing workflows for comprehensive drug resistance profiling of Mycobacterium tuberculosis cultures using two commercial sequencing platforms: Comparison of analytical and diagnostic performance, turnaround time, and cost","volume":"66","author":"Tafess","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.ebiom.2025.105875_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1206056","article-title":"Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing","volume":"11","author":"Murphy","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105875_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02338-2020","article-title":"Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs","volume":"57","author":"Jouet","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ebiom.2025.105875_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.707244","article-title":"A comprehensive evaluation of GeneLEAD VIII DNA platform combined to deeplex Myc-TB((R)) assay to detect in 8 days drug resistance to 13 antituberculous drugs and transmission of Mycobacterium tuberculosis complex directly from clinical samples","volume":"11","author":"Bonnet","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ebiom.2025.105875_bib24","series-title":"Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: rapid communication, July 2023","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105875_bib25","series-title":"Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)","year":"2021"},{"key":"10.1016\/j.ebiom.2025.105875_bib26","series-title":"Catalogue of mutations in mycobacterium tuberculosis complex and their association with drug resistance","year":"2021"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105875_bib27","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1016\/S2666-5247(21)00301-3","article-title":"The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis","volume":"3","author":"Walker","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2025.105875_bib28","series-title":"GenoType MTBDRplus VER 2.0. Instructions for use. IFU-304A-09","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105875_bib29","series-title":"GenoType MTBDRsl VER 2.0. Instructions for use. IFU-317A-04","year":"2023"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105875_bib30","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1164\/rccm.201312-2140OC","article-title":"Xpert MTB\/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression","volume":"189","author":"Hanrahan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105875_bib31","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/JCM.01196-16","article-title":"First evaluation of GenoType MTBDRplus 2.0 performed directly on respiratory specimens in central America","volume":"54","author":"Lanzas","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105875_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1473-3099(21)00452-7","article-title":"Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: a cross-sectional multicentre diagnostic accuracy study","volume":"22","author":"Penn-Nicholson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105875_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5588\/ijtld.22.0138","article-title":"Clinical utility of target-based next-generation sequencing for drug-resistant TB","volume":"27","author":"Mansoor","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ebiom.2025.105875_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103003","article-title":"Cost-effectiveness of targeted next-generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysis","volume":"79","author":"Shrestha","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:40:13Z","timestamp":1772905213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425003196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["S2352396425003196"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105875","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105875"}}